International Journal of Scientific and Research Publications

IJSRP, Volume 4, Issue 3, March 2014 Edition [ISSN 2250-3153]


Significance and prevalence of Tamoxifen related endometrial changes in patients of carcinoma breast
      Marcus S. MD, DNB., Mahajan MK. MD, MNAMS, Grover S. MD, DNB, DGO, 4Sachdev J. MD, Jeyaraj P. MD, Mukhopadhyay S. MD
Abstract: Tamoxifen acts as an estrogen agonist on the female genital tract. The side effect of major concern is endometrial carcinoma.

Reference this Research Paper (copy & paste below code):

Marcus S. MD, DNB., Mahajan MK. MD, MNAMS, Grover S. MD, DNB, DGO, 4Sachdev J. MD, Jeyaraj P. MD, Mukhopadhyay S. MD (2018); Significance and prevalence of Tamoxifen related endometrial changes in patients of carcinoma breast; Int J Sci Res Publ 4(3) (ISSN: 2250-3153). http://www.ijsrp.org/research-paper-0314.php?rp=P272430
©️ Copyright 2011-2022 IJSRP - All rights reserved. Use of this web site signifies your agreement to the terms and conditions.